AGL - agilon health, inc.
NYSE
->
Healthcare
->
Medical Care Facilities
Long Beach,
United States
Type: Equity
AGL price evolution
AGL
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $116.34 | $118.55 | $114.33 | |
| Short term investments | $291.62 | $307.36 | $380.77 | |
| Net receivables | $1368.35 | $1437.04 | $1571.14 | $942.46 |
| Inventory | ||||
| Total current assets | $1811.76 | $1884.01 | $2036.81 | $1480.08 |
| Long term investments | ||||
| Property, plant & equipment | $39.69 | $27.82 | $27.54 | $27.58 |
| Goodwill & intangible assets | $98.95 | $96.21 | $87.9 | |
| Total noncurrent assets | $279.31 | $279.65 | $260.79 | |
| Total investments | $291.62 | $307.36 | $380.77 | |
| Total assets | $2091.41 | $2163.32 | $2316.46 | $1740.87 |
| Current liabilities | ||||
| Accounts payable | $218.49 | $1378.56 | $1519.15 | $970.91 |
| Deferred revenue | ||||
| Short long term debt | $8.75 | $7.5 | $6.25 | |
| Total current liabilities | $1409.16 | $1387.31 | $1526.65 | $977.16 |
| Long term debt | $34.88 | $27.36 | $29.83 | $32.31 |
| Total noncurrent liabilities | $100.14 | $101.33 | $102.69 | |
| Total debt | $36.11 | $37.33 | $38.56 | |
| Total liabilities | $1516.54 | $1487.45 | $1627.98 | $1079.85 |
| Shareholders' equity | ||||
| Retained earnings | -$1481.19 | -$1363.57 | -$1332.89 | -$1326.83 |
| Other shareholder equity | $0.3 | -$2.45 | -$2.75 | -$2.3 |
| Total shareholder equity | $676.63 | $689.27 | $661.84 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $114.33 | $507.68 | $1054.82 | $135.18 |
| Short term investments | $380.77 | $411.9 | ||
| Net receivables | $942.46 | $497.57 | $293.41 | $144.56 |
| Inventory | ||||
| Total current assets | $1480.08 | $1451.27 | $1367.19 | $294.2 |
| Long term investments | ||||
| Property, plant & equipment | $27.58 | $33.08 | $9.16 | $6.46 |
| Goodwill & intangible assets | $87.9 | $109.22 | $96.94 | $102.01 |
| Total noncurrent assets | $260.79 | $246.19 | $219.06 | $152.16 |
| Total investments | $380.77 | $411.9 | ||
| Total assets | $1740.87 | $1697.47 | $1586.25 | $446.36 |
| Current liabilities | ||||
| Accounts payable | $970.91 | $183.36 | $351.96 | $260.11 |
| Deferred revenue | ||||
| Short long term debt | $6.25 | $5 | $5 | $3.04 |
| Total current liabilities | $977.16 | $535.09 | $356.96 | $266.83 |
| Long term debt | $32.31 | $38.48 | $43.4 | $64.67 |
| Total noncurrent liabilities | $102.69 | $121.77 | $137.7 | $154.76 |
| Total debt | $38.56 | $43.48 | $48.4 | $67.71 |
| Total liabilities | $1079.85 | $656.25 | $494.66 | $421.59 |
| Shareholders' equity | ||||
| Retained earnings | -$1326.83 | -$1064.23 | -$957.68 | -$551.19 |
| Other shareholder equity | -$2.3 | -$5.56 | ||
| Total shareholder equity | $661.84 | $1041.22 | $1091.9 | -$284.73 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1482.76 | $1604.35 | $815.5 | |
| Cost of revenue | $1450.58 | $1529.27 | $910.8 | |
| Gross Profit | $32.17 | $75.09 | -$95.3 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $69.61 | $76.42 | $63.28 | |
| Total operating expenses | $75.52 | $82.27 | $64.31 | |
| Operating income | -$43.34 | -$7.18 | -$159.6 | |
| Income from continuing operations | ||||
| EBIT | -$28.57 | -$4.91 | -$228.28 | |
| Income tax expense | $0.42 | -$0.13 | $0.27 | |
| Interest expense | $1.7 | $1.28 | $1.89 | |
| Net income | ||||
| Net income | -$30.68 | -$6.06 | -$230.43 | |
| Income (for common shares) | -$30.68 | -$6.06 | -$230.43 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $4316.36 | $2708.21 | $1833.56 | $1218.33 |
| Cost of revenue | $4246.69 | $2595.93 | $1757.15 | $1124.18 |
| Gross Profit | $69.67 | $112.29 | $76.41 | $94.15 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $285.76 | $218.94 | $455.82 | $137.29 |
| Total operating expenses | $301.8 | $232.72 | $470.37 | $150.82 |
| Operating income | -$232.13 | -$120.43 | -$393.95 | -$56.67 |
| Income from continuing operations | ||||
| EBIT | -$255.15 | -$100.39 | -$399.45 | -$51.05 |
| Income tax expense | $0.79 | $1.64 | $0.89 | $0.86 |
| Interest expense | $6.66 | $4.53 | $6.15 | $8.13 |
| Net income | ||||
| Net income | -$262.6 | -$106.55 | -$406.49 | -$60.05 |
| Income (for common shares) | -$262.6 | -$106.55 | -$406.49 | -$60.05 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | -$30.68 | -$6.06 | -$230.43 | |
| Operating activities | ||||
| Depreciation | $5.91 | $5.84 | $5.15 | |
| Business acquisitions & disposals | $1.42 | |||
| Stock-based compensation | $18.21 | $16.91 | $15.52 | |
| Total cash flows from operations | -$18.72 | -$47.78 | -$61.17 | |
| Investing activities | ||||
| Capital expenditures | -$3.31 | -$3.14 | -$3.93 | |
| Investments | $27.98 | $66.02 | $11.76 | |
| Total cash flows from investing | $116.22 | $18.22 | $51.44 | -$2.2 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$0.46 | $1.81 | $0.41 | |
| Net borrowings | -$1.25 | -$1.25 | -$1.25 | |
| Total cash flows from financing | -$2.56 | -$1.71 | $0.56 | -$0.84 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $39.46 | -$2.21 | $4.22 | -$64.21 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$262.6 | -$106.55 | -$406.49 | -$60.05 |
| Operating activities | ||||
| Depreciation | $20.16 | $13.77 | $14.67 | $14.1 |
| Business acquisitions & disposals | -$43.06 | $0.5 | -$1.34 | $26.2 |
| Stock-based compensation | $69.5 | $28.38 | $292.39 | $6.69 |
| Total cash flows from operations | -$156.2 | -$130.81 | -$148.16 | -$53.2 |
| Investing activities | ||||
| Capital expenditures | -$15.83 | -$15.43 | -$6.56 | -$1.77 |
| Investments | $29.86 | -$412.23 | -$75.74 | -$1.79 |
| Total cash flows from investing | -$44.02 | -$444.39 | -$90.51 | $22.07 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$188.13 | $33.06 | $1189.03 | $27.66 |
| Net borrowings | -$5 | -$5 | -$19.9 | -$3.04 |
| Total cash flows from financing | -$193.13 | $28.06 | $1154.39 | $24.62 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$393.35 | -$547.14 | $915.73 | -$6.52 |
News
Fundamentals
| Market cap | $1.00B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 411.96M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 1.63 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.29 |
| Quick ratio | N/A |